Flow cytometry analysis of LLC-tumor-bearing lungs at day 20 (Fig. 8a) revealed an increased proportion of CD8+ T cells, CD4+ T cells and NK cells following IV BCG treatment (Fig. 8b), accompanied by enhanced cytotoxic potential evidenced by increased Granzyme B expression (Fig. 8c). This evidence concerns the gene CD8A and neoplasm.